Cytel obtains United States patent.

Cytel Corporation (San Diego, CA) has patented improved methods for the formation of glycosidic linkages. These methods are useful for the preparation of compounds of formula: NeuAc Alpha (2 -> 3)Gal Beta (1 -> 4)(Fuc Alpha 1 -> 3)GlcN(R') Beta (1 -> 3)Gal Beta -OR. ()

COPYRIGHT 1999 Biotech Patent News
No portion of this article can be reproduced without the express written permission from the copyright holder.

Reader Opinion

Article Details
Printer friendly Cite/link Email Feedback
Publication:	BIOTECH Patent News
Geographic Code:	1USA
Date:	Apr 1, 1999
Words:	46
Previous Article:	Pioneer Hi-Bred obtains United States patent.
Next Article:	Novartis obtains United States patent.
Topics:	Drugs

Related Articles
Biotech targets layoffs, shifts gears on research. (Cytel Corp.)
United States companies are ignoring technology assets with a potential commercial value well in excess of $115 billion, according to a recently...
CytoTherapeutics acquires stem cell product pipeline
STATXACT 4 HELPS PLAN SAMPLE SIZES FOR STATISTICAL STUDIES.
Cytel's shutdown shifts focus to sister firm.(Cytel Corp.; Epimmune Inc.)(Company Profile)
TKT updates status of erythropoietin litigation.
Hollis-Eden expands its intellectual property position and acquires minority interest in Aeson Therapeutics.(Brief Article)
Altarex licenses United States issued patents for autoimmune disease therapy.(Brief Article)
CYTEL DEBUTS EAST V3.0.
MorphoSys widens scope of United States patent for HuCAL technology.(Human Combinatorial Antibody Library)